Brief: Hansoh Pharmaceutical Says Clinical Trial Approvals For HS-20136-2 Injection Issued- By NMPA
02/07/2026 16:24
BRIEF-Hansoh Pharmaceutical Says Clinical Trial Approvals For HS-20136-2 Injection Issued- By NMPA July 2 (Reuters) - Hansoh Pharmaceutical Group Company Ltd 3692.HK:
CLINICAL TRIAL APPROVALS FOR HS-20136-2 INJECTION ISSUED- BY NMPA
Further company coverage: 3692.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansoh Pharmaceutical
See all newsHansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
Deals of the day-Mergers and acquisitions
Factbox: Major drugmakers turn to China for licensing deals
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion (updated)
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion